China Tower’s Stock Price Soars to 0.94 HKD, Reporting a Positive Leap of 1.08%

China Tower (788)

0.94 HKD +0.01 (+1.08%) Volume: 167.2M

China Tower’s stock price sees a steady climb, currently at 0.94 HKD, marking a trading session increase of +1.08% and a remarkable YTD growth of +14.63%. With a robust trading volume of 167.2M, the stock’s performance continues to impress investors.

Latest developments on China Tower

Key events leading up to today’s stock price movements for China Tower (00788.HK) include both bullish and bearish block trades. A bullish block trade of China Tower’s shares involved 3.2M shares at $0.94, resulting in a turnover of $3.008M. In contrast, a bearish block trade saw 1.6M shares at the same price, yielding a turnover of $1.504M. Additionally, China Tower recently signed a Strategic Cooperation Framework Agreement with the Government of Shanxi Province, potentially influencing stock performance.

A look at China Tower Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a leading telecommunication company in China, has received high scores across various factors according to Smartkarma Smart Scores. With top marks in Value and Dividend, investors can expect strong returns and steady income from this company. Additionally, its impressive Momentum score indicates that China Tower is on a positive trajectory for future growth.

However, the company’s lower Resilience score may raise some concerns about its ability to withstand economic downturns. Despite this, China Tower’s overall outlook remains promising, especially with its solid Growth score. As a key player in the telecommunication industry in China, China Tower is well-positioned to capitalize on the country’s increasing demand for telecommunication services.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma